Niagen Bioscience is headquartered in Los Angeles, California.
Niagen Bioscience disclosed revenue of 100M USD for 2024 and 84M USD for 2023.
Niagen Bioscience has 104 employees.
Niagen Bioscience is a life science company.
Niagen Bioscience was founded in 1999.
10900 Wilshire Boulevard, Suite 600,
Los Angeles, California
90024
United States,
(310) 388-6706
www.niagenbioscience.com
Niagen Bioscience is a provider in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. The company works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality. Niagen Bioscience was founded in 1999 and is based in Los Angeles, California.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $6M | $6M | ||||||
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
